On December 24, 2024, Shanghai VastProTechnology Development Co., Ltd. completed the relocation to Anji, Zhejiang Province and changed its name to VastPro (Zhejiang) Pharmaceutical Co., Ltd. VastPro (Zhejiang) Pharmaceutical Co., Ltd. has two wholly-owned subsidiaries, VastPro (Shanghai) Pharmaceutical Technology Development Co., Ltd. and VastPro (Zhejiang) Technology Development Co., Ltd., which will operate under the new organizational structure. 

       We concentrated on the green synthesis technology innovation and the effective manufacture of challenged pharmaceutical molecules derived from natural products, to establish a professional production platform and business platform, to be the first-class green manufacturing enterprises for high-end pharmaceuticals and functional materials. At current stage, in response to the huge unmet demand for clinical drugs for the nervous system, autoimmune system and anti-tumor, we develop innovative drugs on the basis of clinically effective natural product molecules with clear target and sure mechanism of action. We are committed to becoming a high-quality pharmaceutical technology innovation and product intelligence manufacturing company.